Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI

Ep. 006 — The $165 Billion AI Payment Rail Nobody Noticed

The government just built the first payment rail explicitly designed for AI agents managing chronic disease — and it goes live in six weeks, designed by former VCs now inside CMS, with 165 million commercial lives already pledged to follow, and almost nobody in tech is paying attention.

Ep. 005 — The Government Will Pay AI Only If You Get Healthier

On July 5, the federal government will start paying AI companies only if their patients actually get healthier — and almost nobody outside healthcare has noticed yet.

Ep. 004 — The Same AI That Heals You Can Hack You

Physicians are already building their own clinical tools — responsibly, with patient privacy designed in from day one. The question isn't whether they should. It's whether the EHRs, the hospitals, and a privacy law written in 1996 for a fax-first world will open up to meet them — or keep forcing innovation to happen in the shadows.

Ep. 003 — The Ambient AI Scribe Billing Bombshell Payers Have Been Waiting For

The ambient AI scribe industry sold itself on burnout relief — but the dirty secret hiding in plain sight is that better documentation means higher billing codes, and a peer-reviewed JAMA paper plus a $2.3B BCBSA study just handed payers the ammunition to declare war.

Ep. 002 — The FDA Is Moving the Goalposts on Clinical AI

The FDA is quietly rewriting the fundamental contract of clinical AI regulation — moving from a pre-market permission slip to a post-market surveillance regime — and every founder, investor, and clinician in this industry needs to understand what that means before the framework lands.